Brain Cancer

The FDA has recommended the manufacturer of a cell-based immunotherapy terminate a phase 2 clinical trial assessing its effectiveness in recurrent or progressive glioblastoma early and pursue a phase 3 trial which may lead to an approval.

The American Brain Tumor Association offers a wealth of online resources for patients with metastatic brain tumors and their loved ones and caregivers.

Researchers try new drug combination to improve overall survival in patients with recurrent high-grade glioma, but are unsuccessful.

The approval of an investigational new drug application will allow Berubicin’s manufacturer to begin studying the investigational drug in adults with glioblastoma who have previously failed their first treatment.

President-elect has a well known personal relationship with cancer as his son Beau Biden was diagnosed with glioblastoma and passed from this disease. This high-profile journey and story had an impact on my own journey with cancer.

From the National Cancer Institute releasing promising research data into the genomic mutations that helped “exceptional responders” survive on treatment when others didn’t, to a 15-year-old Kentucky cancer survivor dying from COVID-19, here’s what’s happening in the cancer landscape this week.

The Food and Drug Administration’s approval of Danyelza comes as a result of two trials that assessed the efficacy of the drug in patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow who did not have sufficient response to prior therapies.

The call that raised the hair on my arms, which is the one I least expected, came at 7:30 a.m. during a sales meeting.

As a caregiver, you rarely have 10 seconds to think or reflect on anything, but with my husband gone now, I find myself looking back more than ever. There are so many things we did right, and so many things I’ll probably always feel unsure of.

After receiving a stage 4 glioblastoma diagnosis, one woman taps into her sense of humor — and turns that into a book.

Each month, we take a look back at the most popular CURE® stories. Here are the top five stories for July 2020.

In honor of the second annual Glioblastoma Awareness Day in the United States, Erica Finamore shares her story of the journey and untimely passing of her husband Jon Marc. But how that passing has still given to the research of brain cancer.

The EndBrainCancer Initiative wants patient concerns reflected in national treatment guidelines.

From a skin cancer survivor raising money for the fight against the novel coronavirus to a Cleveland Browns fan who has survived a rare brain tumor helping to open the broadcast of Thursday’s NFL Draft, here’s what is making headlines in the cancer space this week.

Going in for an infusion amid the coronavirus pandemic with a possible "symptom" of COVID-19 and wondering what risks lie ahead.

At the best of times, cancer is a difficult burden to bear, but in the midst of a pandemic, it's especially worse. But patients with cancer know the way out is by going through.

One survivor offers her suggestions to handle chemo brain as she copes with her almost-10-year-old chemo brain.

With the start of a new decade, a brain cancer patient discovers what may be the most courageous way to move forward in his life.

From a weight loss drug’s possible cancer risk to a shocking cancer revelation in the death of ESPN reporter Edward Aschoff, here’s what is making headlines in the cancer space this week.